The DOI matches its Crossref record, with a small difference in title or year; 49 of the 49 references it cites were found in a registry or an index.
Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
Open accessAbstract
SUMMARY: We investigated the production of IL-2, IFN-γ, IL-10 and IL-4 by PBMC from 24 patients with SLE and 10 healthy individuals. Basal and mitogen-stimulated (lipopolysaccharide and phytohaemagglutinin (LPS + PHA)) cytokine production was determined in a whole blood assay (WBA). Supernatants were collected and assayed with specific ELISAs. Although the IL-2 and IFN-γ contents did not differ significantly between patients and controls under both conditions, statistically significant correlations were found between each cytokine and disease activity (SLAM index) after stimulation (respectively, r= 0.501, P = 0.01 and r = 0.631, P = 0.001). PBMC IL-10 production was significantly higher for patients than controls (P = 0.05), but no correlation between IL-10 levels and the SLAM index was obtained. IL-4 production was not statistically different between SLE patients and controls. For stimulated WBAs, the IL-10/IL-2 and IL-10/IFN-γ ratios were significantly correlated with disease severity (P = 0.02; P = 0.001, respectively). Overall, our data suggest that SLE is characterized by an elevated production of IL-10, reflecting the basal state of activation of the immune system. During exacerbation of SLE, IL-2 and IFN-γ are synthesized in larger amounts and may cause the tissue damage observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In adaptative immune regulation, •NO inhibits the lymphocytes T helper 1 (Th1 is a population characterized by the release of IL-2 and IFN-γ) and promotes Th2 lymphocytes, which leads to humoral immunity and allergic responses [113].”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Lymphokine Production by Human T Cells in Disease States
Romagnani, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001303 · Cited by 1,332
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Cherwinski, H., Schumacher, J., Brown, K., & Mosmann, T. (1987) · Journal of Experimental Medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,118
Human TH1 and TH2 subsets: doubt no more
Romagnani, S. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90120-i · Cited by 1,079
Research works printed but not linked: 5
- 10.1146/annurev.immunol.7.1.145 · DOI · Paper page
- Asherson RA, 1988, J Rheumatol, 15, 1742
- Llorente L, 1993, Eur Cytokine Netw, 4, 421
- 10.1146/annurev.immunol.11.1.165 · DOI
- Draeger AM, 1986, Clin Exp Immunol, 64, 80
Cited by
Sorted by citations
Items 201–248 of 248
Construction, purification, and characterization of a chimeric TH1 antagonist
Rivero, I. B., Torrez-Ruiz, Y., Blanco-Garcés, E., Pentón‐Rol, G., Batista, O. F., González, L. J., Gerónimo, H., & López-Saura, P. A. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-25 · Cited by 4
Urinary mRNA in Systemic Lupus Erythematosus
Szeto, C., Kwan, B. C., & Tam, L. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800096-0.00005-6 · Cited by 4
Masson, C., & Yakova, M. (1999) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(00)80090-9 · Cited by 4
Christensen, S. H., Lewis, J. I., Frøkiær, H., Johnsen, P. R., Peerson, J. M., Tan, X., Shahab‐Ferdows, S., Hampel, D., Islam, M. M., Kac, G., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323204 · Cited by 3
“The ratios between the Th1 cytokine IFN-γ and either of the Th2 cytokines IL-4, IL10 or IL-33 have been used in plasma to assess the balance between the activated Th1 and Th2 response with higher ratios reflecting a Th1 dominating response [48,49].”
Immunomodulatory effects of trans-anethole-treated Staphylococcus aureus Newman strain
Kwiatkowski, P. A., Rogulska, K., Pruss, A., Sienkiewicz, M., Dołęgowska, B., & Wojciechowska‐Koszko, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-34138-3 · Cited by 3
An Updated Review of Nicotine in Gastrointestinal Diseases
Wal, P., Aziz, N., Patel, A., & Wal, A. (2023) · The Open Public Health Journal · doi:10.2174/0118749445271127231116130459 · Cited by 2
Solyman, S. M., Kamal, S. A., & Hanora, A. (2025) · Current Microbiology · doi:10.1007/s00284-025-04102-7 · Cited by 3
“Mouse antibodies for IL-2, IL-10, and IFN-γ were used to coat 96-well plates [31].”
T-helper 1 Immune Response in Systemic Lupus Erythematosus and its Relation to Disease Activity
Ghonemy, T. A., Salim, E. M., Al-Hendi, Y. A., & Okely, A. M. E. (2010) · Arab Journal of Nephrology and Transplantation · doi:10.4314/ajnt.v2i3.58877 · Cited by 2
Alteration in cytokines secretion with Type 2 Diabetes mellitus
Said, N. M., & El-shaer, N. H. (2019) · Biochemistry Letters · doi:10.21608/blj.2019.47558 · Cited by 2
“IL-12 is Th1 inducing cytokine whereas IL-2 is Th1 cytokine that mediate the function of Th1 cells [27, 28].”
BackgroundChegni, H., & Heidarvand, M. (2022) · Lupus · doi:10.1177/09612033221098533 · Cited by 2
Effect of spirulina supplementation on selected components of Th1/Th2 balance in rowers
Juszkiewicz, A., Basta, P., Trzeciak, J., Petriczko, E., Cieślicka, M., & Skarpańska-Stejnborn, A. (2019) · Food and Agricultural Immunology · doi:10.1080/09540105.2018.1561830 · Cited by 3
“In contrast, IFN-gamma inhibits the differentiation of Th lymphocytes to Th2 cells and hence, promotes cellular response (Kicielińska & Pajtasz-Piasecka, 2014; Kidd, 2003; Viallard et al., 1999).”
BackgroundCytokines and Chemokines in Human Autoimmune Skin Disorders
Nashan, D., & Schwarz, T. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0171-8_13 · Cited by 2
Khodabakhsh, F., Inanlou, D. N., Asgary, V., Bigdeli, R., Mirmoosa, S. S., Farhoudi, R., & Cohan, R. A. (2023) · BioNanoScience · doi:10.1007/s12668-023-01248-1 · Cited by 1
“It was reported that cytokines IL-4, IL-5, IL-6, and IL-10, produced by Th 2 cells, are responsible for antibody production [15].”
Alshamrani, S., Mashraqi, M. M., Alzamami, A., Alturki, N. A., Almasoudi, H. H., Ahmed, I., & Basharat, Z. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2480263 · Cited by 1
“Interferon-gamma (IFN-g) and interleukin-2 (IL-2) are cytokines produced by various immune cells, including T cells, that play important roles in regulating immune responses (Viallard et al., 1999).”
Mohammadi, Y., Saghaei, M., Saghi, M., Mazhari, S. A., Alani, B., Ehtesham, N., Kenarangi, T., & Soosanabadi, M. (2025) · Lupus · doi:10.1177/09612033251331256 · Cited by 1
Research progress on milk and egg allergens
Pan, F., Wang, R., Liu, J., Tan, S., & Luo, X. (2025) · European Food Research and Technology · doi:10.1007/s00217-025-04923-7 · Cited by 1
Viscidi, R. P., Huang, J., Li, Y., Severance, E. G., & Xiao, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-49283-8 · Cited by 1
Biology of TH17 Cells and Their Role in Inflammatory Diseases
Tari, K., Rahimi, A., Atashi, A., Pourfathollah, A. A., & Mesdaghi, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Immunobioengineering Approaches Towards Combinatorial Delivery of Immune-Modulators and Antigens
Singh, A. K., Pradhan, P., & Roy, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5380-2_8 · Cited by 1
Nakonechnaya, T., Shagina, I. A., Myshkin, M. Y., Mutovina, Z. Y., Ryazantseva, E. V., Chudakov, D. M., Turchaninova, M. A., & Britanova, O. (2024) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2024.027 · Cited by 1
Interferon-gamma and systemic lupus erythematosus
Xia, J., & Su, X. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2010.01020 · Cited by 1
ANKDD1A may serve as a critical gene in the immune microenvironment of breast cancer
Zhao, P., Fu, Y., Yang, X. L., Abdoulaye, H. A., Rauniyar, R., Peng, J., Wang, M., Wang, H., Ning, M., Chen, Y., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2685 · Cited by 1
“Of them, Th1 cells enhance cellular immunity through secreting IFN-γ and IL-2 (16), while Th2 cells inhibit cellular immunity and promote humoral immunity by secreting IL-4, IL-5 and IL-10 (17,18).”
BackgroundVidosava, B., Zvezdanovi, L., Vlahovi, P., Kundali, S., Jevtovi, T., Stamenkovi, B., & Mitrovi, D. R. (2010) · Cited by 1
Garcia, L. F. M. (2012) · Americanae (AECID Library) · Cited by 1
Dempsey, E. (2006) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/d7kk6m
Rôle des cytokines dans la physiopathologie du lupus
Viallard, J., Taupin, J.-L., Ranchin, V., Leng, B., Pellegrin, J., & Moreau, J. (2000) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(00)80019-8
Self-citationIL-10 Single Nucleotide Polymorphisms and Lupus-Nephritis
Dourmishev, L., Hristova, M. H., Vinkov, A. I., Kamenarska, Z. G., Kaneva, R. P., Baleva, M. P., & Mitev, V. (2012) · Biotechnology & Biotechnological Equipment · doi:10.5504/bbeq.2012.0036
Susceptibility genes in systemic lupus erythematosus
Hellquist, A. (2009) · Figshare
Characterization of lymph node stromal cells during Treg-mediated tolerance
Fakultät, P.-N. (2013)
Kumar, S., Sharma, G., Sidiq, T., Khajuria, A., Jain, M., Bhagwat, D., & Dhar, K. L. (2016)
Distinct Roles of GABA(A)R Signaling in the Regulation of Two Human T lymphocyte Lines
Lin, Y. (2017) · Scholarship@Western (Western University)
The role of invariant Natural Killer T cells in SLE patients with atherosclerosis
Smith, E. C. (2016) · UCL Discovery (University College London)
Higuchi, L. M., Regan, B. P., & Bousvaros, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_30
Assogba, Y. P., Adechina, A. P., Tchiakpé, E., Nouatin, O. P., Kêkê, R. K., Bachabi, M., Bankole, H. S., & Yessoufou, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3303851/v1
Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus
Bohat, R., Liang, X., Chen, Y., Xu, C., Zheng, N., Guerrero, A. M., Hou, J., Jaffery, R., Egan, N. A., Li, Y., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109874
Lazebnik, T., & Friedman, A. (2025) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2025.112069
Modulation of T Cell Regulation by Interleukin-2 Agonists: Mechanisms and Clinical Implications
Sonak, S. S., Ishwarkar, S., Nimbarte, C., & Nimbarte, V. D. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025059823
Crosio, G., King, E. R., & Huang, A. H. (2025) · The FASEB Journal · doi:10.1096/fj.202500544r
“Flow cytometry analysis of T-cell markers showed a large proportion of cells were IFN-γ producing, indicating that these were likely pro-inflammatory type 1 helper T cells (Th1), as this secreted cytokine is a traditional marker for these cells [34].”
The role of effector T-cells in the pathogenesis op lupus nephritis
Dolff, S. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Latour, E., Arlet, J., Latour, E. E., Juszkiewicz, A., Łuczkowska, K., Marcinkiewicz, A., Basta, P., Trzeciak, J., Machaliński, B., & Skarpańska-Stejnborn, A. (2021) · Figshare · doi:10.6084/m9.figshare.14998899
Subramanian, N., Hofwimmer, K., Tavira, B., Massier, L., Andersson, D. P., Arner, P., & Laurencikiene, J. (2023) · Figshare · doi:10.6084/m9.figshare.22623614
Synthetic immunomodulators: Revolutionizing immunotherapy
Surendranath, A., Adan, A. M., Abdulla, A., Hakeem, F., Abdelgani, W. B. M., Akil, A. S. A.-S., & Bhat, A. A. (2026) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2026.02.002
Arumugam, D., & Ghosh, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.27.714640
Genetic variations influencing immune response
Hussain, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00005-8
Ansarifard, F., & Nasrollahzadeh, J. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100540
BindingDB (2022) · UC San Diego · doi:10.7270/q2st7tk7
Zaher, M. R., & El-Husseini, D. M. (2026) · Research Square · doi:10.21203/rs.3.rs-11527358/v1 · Cited by 1
Metadata
- Authors
- VIALLARD, J. F., PELLEGRIN, J. L., RANCHIN, V, SCHAEVERBEKE, T., DEHAIS, J., LONGY-BOURSIER, M., RAGNAUD, J. M., LENG, B., & MOREAU, J. F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
- Laboratoire Immunotech, Marseille
- Hôpital Pellegrin (FR)
- Service de Médecine Interne, Hôpital Saint-André
- Corresponding author
- VIALLARD, J F
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-01
- Volume
- 115
- Issue
- 1
- Pages
- 189-195
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- PMC
- PMC1905189
- OpenAlex
- W2030175762
- Cited by
- 247
- References
- 48
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 13 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 5 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 16 · 2013: 4 · 2012: 13
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical & Experimental Immunology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- systemic lupus erythematosus, Th1/Th2 balance, interleukin-2, interferon-gamma, IL-10, IL-4, peripheral blood mononuclear cells, disease activity, cytokine ratios, immune activation, tissue damage
- MeSH terms
- Adolescent, Adult, Female, Humans, Interferon-gamma, Interleukin-2, Leukocytes, Mononuclear, Lupus Erythematosus, Systemic, Male, Middle Aged, Interleukin-4, Cytokines, Interleukin-10, Th1 Cells, Th2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
